Table: Torii Pharmaceutical - Q1 parent results
Apr 27 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2017 Mar 31, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 13.61 13.74 64.50
(-1.0 pct) (+3.3 pct) (+7.1 pct)
Operating 533 mln 1.18 5.30
(-54.9 pct) (+59.0 pct) (+38.8 pct)
Recurring 555 mln 1.22 5.40
(-54.6 pct) (+54.0 pct) (+35.0 pct)
Net 388 mln 803 mln 3.90
(-51.6 pct) (+50.8 pct) (+37.3 pct)
EPS 13.85 yen 28.39 yen 139.04 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)